Ye Hui, Song Liang, Li Qingli, Shen Chongyang, He Yuedong, Li Lin
Department of Gynecology, West China Second University Hospital, Sichuan University Chengdu 610041, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education Chengdu 610041, Sichuan, China.
Am J Cancer Res. 2025 May 15;15(5):1988-2003. doi: 10.62347/FNTD1712. eCollection 2025.
Cervical cancer poses a serious threat to women's lives and health, and it may cause damage to the reproductive system, infertility, and even death. This study reviews the research progress of organoids in the treatment of cervical cancer. Studies have found that the culturing of tumor cell lines and the modeling techniques of tumor xenotransplantation for cervical cancer have certain limitations. Cervical cancer organoids are preclinical research models formed by culturing tumor cells derived from patients, which more accurately and effectively retain tumor heterogeneity, and also have the potential to take into account the interaction between tumor cells and the extracellular matrix. This article reviews the research on cervical cancer organoid models in the pathogenesis, drug screening, and precision medicine aspects in recent years, and then analyzes the development prospects and challenges of organoid technology in gynecological tumor research, in order to explore new possibilities for individualized treatment of cervical cancer.
宫颈癌对女性的生命和健康构成严重威胁,可能会对生殖系统造成损害、导致不孕,甚至死亡。本研究综述了类器官在宫颈癌治疗中的研究进展。研究发现,宫颈癌的肿瘤细胞系培养及肿瘤异种移植建模技术存在一定局限性。宫颈癌类器官是通过培养患者来源的肿瘤细胞形成的临床前研究模型,能更准确有效地保留肿瘤异质性,还具有兼顾肿瘤细胞与细胞外基质间相互作用的潜力。本文综述了近年来宫颈癌类器官模型在发病机制、药物筛选和精准医学方面的研究,进而分析类器官技术在妇科肿瘤研究中的发展前景与挑战,以期探索宫颈癌个体化治疗的新可能。